RT Journal Article
T1 Infective Endocarditis Following Transcatheter Aortic Valve Replacement: Comparison of Balloon- Versus Self-Expandable Valves.
A1 Regueiro, Ander
A1 Linke, Axel
A1 Latib, Azeem
A1 Ihlemann, Nikolaj
A1 Urena, Marina
A1 Walther, Thomas
A1 Husser, Oliver
A1 Herrmann, Howard
A1 Nombela-Franco, Luis
A1 Cheema, Asim
A1 Le Breton, Hervé
A1 Stortecky, Stefan
A1 Kapadia, Samir
A1 Bartorelli, Antonio
A1 Sinning, Jan Malte
A1 Amat-Santos, Ignacio
A1 Munoz-Garcia, Antonio
A1 Lerakis, Stamatios
A1 Gutíerrez-Ibanes, Enrique
A1 Abdel-Wahab, Mohamed
A1 Tchetche, Didier
A1 Testa, Luca
A1 Eltchaninoff, Helene
A1 Livi, Ugolino
A1 Castillo, Juan Carlos
A1 Jilaihawi, Hasan
A1 Webb, John
A1 Barbanti, Marco
A1 Kodali, Susheel
A1 de Brito Jr, Fabio
A1 Ribeiro, Henrique
A1 Miceli, Antonio
A1 Fiorina, Claudia
A1 Actis Dato, Guglielmo Mario
A1 Rosato, Francesco
A1 Serra, Vicenç
A1 Masson, Jean-Bernard
A1 Wijeysundera, Harindra
A1 Mangione, Jose
A1 Ferreira, Maria-Cristina
A1 Lima, Valter
A1 Carvalho, Luis
A1 Abizaid, Alexandre
A1 Marino, Marcos
A1 Esteves, Vinicius
A1 Andrea, Julio
A1 Messika-Zeitoun, David
A1 Himbert, Dominique
A1 Kim, Won-Keun
A1 Pellegrini, Costanza
A1 Auffret, Vincent
A1 Nietlispach, Fabian
A1 Pilgrim, Thomas
A1 Durand, Eric
A1 Lisko, John
A1 Makkar, Raj
A1 Lemos, Pedro
A1 Leon, Martin
A1 Puri, Rishi
A1 San Roman, Alberto
A1 Vahanian, Alec
A1 Søndergaard, Lars
A1 Mangner, Norman
A1 Rodés-Cabau, Josep
K1 endocarditis
K1 incidence
K1 registry
K1 transcatheter aortic valve replacement
AB No data exist about the characteristics of infective endocarditis (IE) post-transcatheter aortic valve replacement (TAVR) according to transcatheter valve type. We aimed to determine the incidence, clinical characteristics, and outcomes of patients with IE post-TAVR treated with balloon-expandable valve (BEV) versus self-expanding valve (SEV) systems. Data from the multicenter Infectious Endocarditis After TAVR International Registry was used to compare IE patients with BEV versus SEV. A total of 245 patients with IE post-TAVR were included (SEV, 47%; BEV, 53%). The timing between TAVR and IE was similar between groups (SEV, 5.5 [1.2-15] months versus BEV, 5.3 [1.7-11.4] months; P=0.89). Enterococcal IE was more frequent in the SEV group (36.5% versus 15.4%; P The characteristics of IE post-TAVR, including microorganism type, vegetation location, and embolic complications but not early or late mortality, differed according to valve type. These results may help to guide the diagnosis and management of IE and inform future research studies in the field.
YR 2019
FD 2019-11-07
LK http://hdl.handle.net/10668/14644
UL http://hdl.handle.net/10668/14644
LA en
DS RISalud
RD Apr 20, 2025